Home/Filings/4/0001415889-22-003184
4//SEC Filing

INGRAM ROBERT ALEXANDER 4

Accession 0001415889-22-003184

CIK 0001701541other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:05 PM ET

Size

5.3 KB

Accession

0001415889-22-003184

Insider Transaction Report

Form 4
Period: 2022-03-18
Transactions
  • Award

    Common Stock

    2022-03-18$3.02/sh+5,795$17,50118,397 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Second Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on March 17, 2022.

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

Related Parties

1
  • filerCIK 0001219890

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:05 PM ET
Size
5.3 KB